Identification of M2 macrophage markers for predicting outcome and therapeutic response in osteosarcoma: Integrated analysis of single-cell and bulk RNA-sequencing

被引:0
作者
Liu, Yang [1 ,2 ]
Liu, Liwei [3 ]
Wei, Xianpeng [4 ]
Xiong, Yan [4 ]
Han, Qifang [4 ]
Gong, Tianhui [4 ]
Tang, Fuzhou [4 ]
Xia, Kaide [3 ]
Zheng, Shuguang [1 ,2 ]
机构
[1] Guizhou Univ Tradit Chinese Med, Guiyang, Peoples R China
[2] Guizhou Univ Tradit Chinese Med, Affiliated Hosp 1, Guiyang, Peoples R China
[3] Guiyang Childrens Hosp, Guiyang Maternal & Child Hlth Care Hosp, Guiyang, Peoples R China
[4] Guizhou Med Univ, Guiyang, Peoples R China
关键词
Single-cell and bulk RNA-sequencing; M2; macrophage; prognostic signature; therapeutic response; osteosarcoma; DISCOVERY;
D O I
10.7150/jca.104855
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Identification of effective biomarkers is crucial to improve the efficacy of immunotherapy in patients with osteosarcoma. Tumor-associated M2 macrophages, an important immune cell type in the tumor immune microenvironment, are closely related to the formation and progression of tumors. However, the relationships of M2 macrophages and prognosis and the immunotherapy response to osteosarcoma remain unclear. In this study, we obtained single-cell RNA sequencing (scRNA-seq) data of osteosarcoma from the gene expression omnibus (GEO) database and performed trajectory analysis and cell communication analysis. We then identified M2 macrophage marker genes based on scRNA-seq data of osteosarcoma, and constructed a risk-score model using these genes. Next, we compared the survival status and immune features of patients with high and low risk scores. Based on scRNA-seq data, we found that macrophages were the major immune cell type in the osteosarcoma microenvironment, and the high proportion of M2 macrophages might result from the transition of macrophages M1 to M2. M2 macrophages communicated with osteoblastic cells via the APP, MIF, and SPP1 signaling pathways, facilitating osteosarcoma development. Moreover, we identified 189 osteosarcoma-related M2 macrophage marker genes and screened out 10 key genes used for model constrcution. These 10 genes consisted of two known M2 macrophage markers and eight novel M2 macrophage marker genes. Low-risk patients have a statistically significant survival advantage, which was verified in the four GEO datasets. Low-risk patients also displayed a high abundance of tumor-infiltrating immune cells, indicative of an "hot" immune phenotype, while high-risk patients displayed an opposite immunologic feature. Notably, our analysis of two independent immunotherapy cohorts revealed that low-risk patients had good immunotherapy responses and outcomes. Additionally, we determined 32 evidently correlated pairs between risk score and drug sensitivity. This study reveals a new prognostic signature based on M2 macrophage marker genes that can help optimize personalized prognosis and improve immunotherapy outcomes in patients with osteosarcoma and also provides a method for identifying effective biomarkers based on integrated analysis of single-cell and bulk RNA sequencing.
引用
收藏
页码:1873 / 1887
页数:15
相关论文
共 37 条
[31]   Comprehensive analysis of cholesterol metabolism-related genes in prostate cancer: integrated analysis of single-cell and bulk RNA sequencing [J].
Jiang, Zixiong ;
Luo, Yu ;
Song, Liangdong ;
Zhang, Jindong ;
Wei, Chengcheng ;
Su, Shuai ;
Wang, Delin .
DISCOVER ONCOLOGY, 2025, 16 (01)
[32]   Combined analysis of bulk and single-cell RNA sequencing reveals novel natural killer cell-related prognostic biomarkers for predicting immunotherapeutic response in hepatocellular carcinoma [J].
Zhang, Kai ;
Yuan, Enwu .
FRONTIERS IN IMMUNOLOGY, 2023, 14
[33]   Unraveling the role of M1 macrophage and CXCL9 in predicting immune checkpoint inhibitor efficacy through multicohort analysis and single-cell RNA sequencing [J].
Yu, Yunfang ;
Chen, Haizhu ;
Ouyang, Wenhao ;
Zeng, Jin ;
Huang, Hong ;
Mao, Luhui ;
Jia, Xueyuan ;
Guan, Taihua ;
Wang, Zehua ;
Lin, Ruichong ;
Huang, Zhenjun ;
Yin, Hanqi ;
Yao, Herui ;
Zhang, Kang .
MEDCOMM, 2024, 5 (03)
[34]   Single-cell RNA datasets and bulk RNA datasets analysis demonstrated C1Q+ tumor-associated macrophage as a major and antitumor immune cell population in osteosarcoma [J].
Tu, Jihao ;
Wang, Duo ;
Zheng, XiaoTian ;
Liu, Bin .
FRONTIERS IN IMMUNOLOGY, 2023, 14
[35]   RNA modification-related EIF4G2 is an immunotherapy determinant in osteosarcoma: A single-cell sequencing analysis [J].
Qin, Haocheng ;
Yang, Shu ;
Feng, Zhennan ;
Wu, Song ;
Cai, Ting ;
Xie, Zijing ;
Hu, Hai .
ENVIRONMENTAL TOXICOLOGY, 2024, 39 (10) :4547-4561
[36]   Integrated analysis of single-cell and bulk RNA sequencing reveals pro-fibrotic PLA2G7high macrophages in pulmonary fibrosis [J].
Wang, Junyi ;
Jiang, Manling ;
Xiong, Anying ;
Zhang, Lei ;
Luo, Li ;
Liu, Yao ;
Liu, Shengbin ;
Ran, Qin ;
Wu, Dehong ;
Xiong, Ying ;
He, Xiang ;
Leung, Elaine Lai-Han ;
Li, Guoping .
PHARMACOLOGICAL RESEARCH, 2022, 182
[37]   Integrated analysis of single-cell and bulk transcriptome identifies a signature based on NK cell marker genes to predict prognosis and therapeutic response in clear cell renal cell carcinoma [J].
Wang, Ke ;
Yu, Mingyang ;
Zhang, Zhouzhou ;
Yin, Rong ;
Chen, Qifeng ;
Zhao, Xuezhi ;
Yu, Hongqi .
TRANSLATIONAL CANCER RESEARCH, 2023, 12 (05) :1270-+